Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Phage display screening identifies a novel peptide to suppress ovarian cancer cells in vitro and in vivo in mouse models

Fig. 1

Efficacy of phage clones in binding to HO8910 versus normal ovarian cells. HO8910 cells and OSE were incubated with phage display peptides. Unbound phages were removed by gentle washing and the bound phage clones were assayed by ELISA after incubation with HRP/anti-M13 and then analyzed with a microplate reader at 450 nm. The mean OD values represent activity of phage binding to cells. M13KE and PBS were used as controls. Lanes 1 to 12 depicts positive phage clones biopanned with HO8910 versus OSE cells

Back to article page